Breast Cancer
Scientists at University of Siena, Department of Physiology discuss research in breast cancer
Published in Gene Therapy Weekly, December 30th, 2010
2010 DEC 30 -- Fresh data on breast cancer are presented in the report 'Interleukin-1ß regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1a.' According to a study from Siena, Italy, "The casual relationship between inflammation and tumor progression has been widely accepted and the etiology of breast cancer has been associated with inflammatory processes. Interleukin (IL)-1ß, besides its central role in inflammation, has also been recognised as a powerful player in tumor progression, angiogenesis and invasiveness."
"Recently, there has been considerable interest in understanding the non-hypoxic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2010-12-30)
More Articles from Gene Therapy Weekly
- Gene Therapy
Data on gene therapy published by E. Martin-Montanez and colleagues - Gene Therapy
Findings from E.Y. Kim and co-authors provide new insights into gene therapy - Antisense Technology
Findings from M. Parrybillings and co-researchers advance knowledge in antisense technology - Gene Therapy
Findings from Northeastern University advance knowledge in gene therapy - Gene Therapy
New gene therapy research from A. Valeri and co-researchers described - Gene Therapy
New gene therapy research reported from University of Florida, Department of Pediatrics - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
